Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 33 days ago
Share
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
1099 patients around the world
Available in
Mexico
AstraZeneca
1099
Patients around the world
This study is for people with
Chronic obstructive pulmonary disease
Copd
Requirements for the patient
To 130 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
OBERON
Sponsor
AstraZeneca
Study type
Interventional
Conditions
Copd
Requirements
To 130 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05166889
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent